D-Index & Metrics Best Publications

D-Index & Metrics

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Immunology D-index 69 Citations 15,785 123 World Ranking 1137 National Ranking 609

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • DNA
  • Immune system

The scientist’s investigation covers issues in Cell biology, Antigen, Immunology, Cytotoxic T cell and Immune system. His biological study spans a wide range of topics, including Interferon and Innate immune system. The various areas that Rongfu Wang examines in his Interferon study include Receptor and Ubiquitin.

Rongfu Wang combines subjects such as Molecular biology and Tumor antigen with his study of Antigen. He regularly links together related areas like Cancer in his Immune system studies. His research in Signal transduction intersects with topics in NLRX1, MDA5 and NLRC5.

His most cited work include:

  • Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli. (1036 citations)
  • Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell Function (645 citations)
  • Tumor-Specific Human CD4+ Regulatory T Cells and Their Ligands: Implications for Immunotherapy (490 citations)

What are the main themes of his work throughout his whole career to date?

Rongfu Wang focuses on Immunology, Cell biology, Antigen, Immune system and Interferon. His work is dedicated to discovering how Immunology, Cancer are connected with Adoptive cell transfer, Oncology and Cell therapy and other disciplines. The study incorporates disciplines such as Receptor and Ubiquitin in addition to Cell biology.

His Antigen study incorporates themes from Cytotoxic T cell, Tumor antigen and Cancer research. His studies deal with areas such as Epitope, T cell and Molecular biology as well as Cytotoxic T cell. In the subject of general Interferon, his work in Interferon type I is often linked to Plasmodium yoelii, thereby combining diverse domains of study.

He most often published in these fields:

  • Immunology (54.50%)
  • Cell biology (69.31%)
  • Antigen (41.27%)

What were the highlights of his more recent work (between 2017-2021)?

  • Cancer research (30.69%)
  • Cell biology (69.31%)
  • Interferon (51.85%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cancer research, Cell biology, Interferon, Signal transduction and Prostate cancer. His work deals with themes such as Carcinogenesis, Cancer, Cellular differentiation, SOX2 and Epigenetics, which intersect with Cancer research. His Cell biology research is multidisciplinary, incorporating elements of KLF2, Regulator gene and Gene expression.

His Interferon research includes elements of CD28, NFAT and Immune system. Rongfu Wang focuses mostly in the field of Immune system, narrowing it down to matters related to MDA5 and, in some cases, Innate immune system. His biological study focuses on Interferon type I.

Between 2017 and 2021, his most popular works were:

  • Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. (113 citations)
  • Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. (113 citations)
  • Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis. (113 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • DNA
  • Cancer

His primary areas of investigation include Cell biology, Interferon type I, Signal transduction, DEAD Box Protein 58 and RNA interference. His Cell biology research is multidisciplinary, incorporating perspectives in RIG-I, Receptor and Interferon.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli.

Rong Fu Wang;Sidney R. Kushner.
Gene (1991)

1300 Citations

Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell Function

Gyangyong Peng;Zhong Guo;Yukiko Kiniwa;Kui Shin Voo.
Science (2005)

888 Citations

Tumor-specific human CD4+ regulatory T cells and their ligands: Implications for immunotherapy

Helen Yicheng Wang;Dean A. Lee;Guangyong Peng;Zhong Guo.
Immunity (2004)

656 Citations

Cancer therapy using a self-replicating RNA vaccine

Han Ying;Tal Z. Zaks;Rong Fu Wang;Kari R. Irvine.
Nature Medicine (1999)

542 Citations

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

Rong Fu Wang;Steven A. Rosenberg.
Journal of Experimental Medicine (1996)

465 Citations

NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways

Jun Cui;Liang Zhu;Liang Zhu;Xiaojun Xia;Helen Y. Wang.
Cell (2010)

457 Citations

Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen

Rong Fu Wang;Xiang Wang;Alicia C. Atwood;Suzanne L. Topalian.
Science (1999)

452 Citations

Regulatory T cells and cancer

Helen Yicheng Wang;Rongfu Wang.
Current Opinion in Immunology (2007)

426 Citations

Human tumor antigens for cancer vaccine development

Rong Fu Wang;Steven A. Rosenberg.
Immunological Reviews (1999)

412 Citations

Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes.

Rong-Fu Wang;P. F. Robbins;Y. Kawakami;Xiao-Qiang Kang.
Journal of Experimental Medicine (1995)

402 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Rongfu Wang

Steven A. Rosenberg

Steven A. Rosenberg

National Institutes of Health

Publications: 69

Lloyd J. Old

Lloyd J. Old

Ludwig Cancer Research

Publications: 69

Nicholas P. Restifo

Nicholas P. Restifo

National Institutes of Health

Publications: 55

Shelley M. Payne

Shelley M. Payne

The University of Texas at Austin

Publications: 42

Yao-Tseng Chen

Yao-Tseng Chen

Cornell University

Publications: 39

Sacha Gnjatic

Sacha Gnjatic

Icahn School of Medicine at Mount Sinai

Publications: 38

Thierry Boon

Thierry Boon

Ludwig Cancer Research

Publications: 37

Xuetao Cao

Xuetao Cao

Nankai University

Publications: 36

Paul F. Robbins

Paul F. Robbins

National Institutes of Health

Publications: 36

Gerd Ritter

Gerd Ritter

Memorial Sloan Kettering Cancer Center

Publications: 30

Alan N. Houghton

Alan N. Houghton

Memorial Sloan Kettering Cancer Center

Publications: 30

Jedd D. Wolchok

Jedd D. Wolchok

Memorial Sloan Kettering Cancer Center

Publications: 30

Dirk Schadendorf

Dirk Schadendorf

University of Duisburg-Essen

Publications: 30

Alessandro Sette

Alessandro Sette

La Jolla Institute For Allergy & Immunology

Publications: 28

Andreas J. Bäumler

Andreas J. Bäumler

University of California, Davis

Publications: 27

Alexander Knuth

Alexander Knuth

University of Zurich

Publications: 27

Trending Scientists

Robert J. Manning

Robert J. Manning

Tyndall National Institute

Karim Abdel-Malek

Karim Abdel-Malek

University of Iowa

Di Wu

Di Wu

Zhengzhou University

C. B. Ammerman

C. B. Ammerman

University of Florida

Carsten Wiuf

Carsten Wiuf

University of Copenhagen

Mario D. Galigniana

Mario D. Galigniana

Experimental Medicine and Biology Institute

Albert O. Brinkmann

Albert O. Brinkmann

Erasmus University Rotterdam

Johannes Oldenburg

Johannes Oldenburg

University of Bonn

Andrew H. Limper

Andrew H. Limper

Mayo Clinic

John R. Jensen

John R. Jensen

University of South Carolina

Xin Liu

Xin Liu

Ocean University of China

Gary L. Westbrook

Gary L. Westbrook

Oregon Health & Science University

Lyn S. Chitty

Lyn S. Chitty

University College London

Tomohide Tamura

Tomohide Tamura

St. Luke's International Hospital

Richard Greil

Richard Greil

Paracelsus Medical University

Something went wrong. Please try again later.